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Summary
Background:Microtubule ends have distinct biochemical and
structural features from those of the lattice. Several proteins
that control microtubule behavior can distinguish the end of
a microtubule from the lattice. The end-binding protein EB1,
for example, recognizes the nucleotide state of microtubule
ends, which are enriched in GTP-tubulin. EB1 shares its
binding site with Doublecortin (DCX), a protein expressed in
developing neurons. We showed recently that DCX binds
with highest affinity to microtubule ends.
Results:Here we show that DCX recognizes microtubule ends
by a novel mechanism based on lattice curvature. Using sin-
gle-molecule microscopy, we show that DCX ‘‘comets’’ do
not elongate at faster microtubule growth rates and DCX
does not recognize two out of three GTP analogs. We demon-
strate that DCXbindswith higher affinity to curvedmicrotubule
lattices than to straight ones. We find that curvature recogni-
tion is a property of single DCX molecules. Straightening of
protofilaments (pfs) at microtubule ends with paclitaxel signif-
icantly attenuates end-recognition by DCX, but not EB1. Muta-
tions in DCX found in patients with double cortex syndrome
disrupted curvature recognition.
Conclusions: We propose a model in which DCX recognizes
microtubule ends through specific interactions with their
structure. We conclude that microtubule ends have two
distinct features that proteins can recognize independently,
namely a structural feature related to curvature and nucleotide
state.
Introduction
Cells regulate the growth and shrinkage of microtubules
primarily through action atmicrotubule ends. As such,microtu-
bule ends are focal points of protein activity [1] where microtu-
bule polymerases, depolymerases, and end-binding proteins
participate in determining the fate of individual microtubules
[2]. A basic question is how these proteins distinguish the
end of a microtubule from the lattice.
Biochemically, tubulin is aGTPase andmicrotubule ends are
stabilized by a ‘‘GTP cap’’ [3], an extended region in which
tubulin dimers have enhanced, nucleotide-dependent lateral
contacts [4]. Structurally, there is a lack of consensus, be-
cause the data describingmicrotubule ends are varied. In elec-
tron micrographs (EM) of growing microtubules, the ends are
not always blunt. Rather, the ends are frequently tapered,
with some protofilaments (pfs) extending beyond others
and curving outward, both in vitro [5] and in mitotic PtK1 cells
[6] and S. pombe [7]. Pfs may curve outward because of a
kink observed at the intradimer interface of GTP-tubulin*Correspondence: gary.brouhard@mcgill.cacomplexes [8, 9] as well as GMPCPP-tubulin [10], which is
presumably straightened by incorporation into the lattice
[11]. Pfs may also curve at the interdimer interface. Within a
single microtubule, the curvature of pfs is variable [6]. Poly-
merizing microtubule ends in vitro have an average curvature
ofw5 per dimer, while microtubule ends in mitotic Ptk1 cells
are more curved (w15 per dimer) [6]. These outwardly curved
pfs are often interpreted as ‘‘sheets’’ [12], a flattened array of
pfs connected by lateral bonds that differ from the lateral
bonds in the closed tube [10]. One possible explanation for
the ‘‘sheet’’ phenomenon is a tapered microtubule end with
two intrinsic curvatures: one that curves pfs outward and
one that closes the pfs into a tube [13]. The balance of these
competing curvatures produces a flattened ‘‘sheet.’’ The vari-
ability in the EM data and in the conditions used to obtain
them, however, has left the structure of microtubule ends
open to debate.
The study of microtubule ends advanced significantly with
the discovery of proteins that ‘‘track’’ them [14], especially
the canonical end-binding protein EB1 [15]. Fluorescent end-
binding proteins appear as ‘‘comets’’ at microtubule ends
and are nowwidely used asmarkers for microtubule dynamics
in live cells [16]. An early hypothesis was that end-binding pro-
teins recognize the nucleotide state of tubulin, namely the GTP
cap, although an alternative hypothesis relating to structural
featureswas also put forward [14]. Themechanismwas settled
by experiments demonstrating that EB1 binds preferentially to
microtubules built from GTP analogs, first GMPCPP [17] then
GTPgS [18]. A cryo-EM reconstruction of EB1 bound to GTPgS
microtubules showed that the calponin-homology domain of
EB1 binds to microtubules at the vertex of four tubulin dimers
and contacts helix H3 of b-tubulin, which coordinates GTP
hydrolysis [4]. EB1 also contacts the region of a-tubulin that
compacts upon GTP hydrolysis [19]. These results provide a
plausible mechanism by which EB1 could recognize the GTP
cap. Many other proteins autonomously recognize the micro-
tubule end, including the microtubule depolymerase MCAK
[20], the polymerase XMAP215 [21], the kinetochore complex
Dam1 [22], and the neuronal microtubule-associated protein
Doublecortin (DCX) [23]. It remains unclear, however, whether
these proteins recognize the same feature of microtubule
ends, namely their nucleotide state, as EB1 does.
EB1 shares its binding site with DCX [24], a microtubule-
associated protein that is mutated in cases of subcortical
band heterotopia and X-linked lissencephaly [25, 26]. The dis-
ease is caused by a breakdown in the radial migration of
cortical neurons, a phenotype reproduced in an animal model
based on in utero electroporation of RNAi constructs [27].
Work in cultured neurons indicates that DCX expression plays
a role in collateral branching [28], arborization of dendrites,
and axon elongation [29]. Consistent with these phenotypes,
DCX appears to bind to microtubules in the leading processes
of migrating neurons [30, 31], extending immature neurites,
and growth cones [28]. DCX controls microtubule dynamics
and stability in these regions, but the molecular mechanism(s)
by which it does so remain unclear.
The contactsmadeby EB1 andDCXwithin their shared bind-





Figure 1. DCX Recognizes Microtubule Ends Differently Than EB1
(A) Schematic of the single molecule assay.
(B) Image of 2.5 nM DCX-GFP (green) binding to the end of a growing microtubule that extended from a seed (magenta).
(C) Image of 100 nM DCX-GFP (green) fully decorating the microtubule extension, creating the appearance of a ‘‘lightsaber.’’
(D) Kymographs depicting the interaction of 2.5 nMDCX-GFP (top) and 5 nMDCX-GFP (bottom) with dynamic microtubules. The signal is broader andmore
intense at 5 nM DCX-GFP than at 2.5 nM DCX-GFP.
(E) Plot of DCX-GFP intensity against the distance from the microtubule end at three different DCX-GFP concentrations (labeled).
(F) Plot of the comet length as a function of DCX-GFP concentration. The comet length increases with higher DCX-GFP concentration until the entire micro-
tubule extension shows an equivalent DCX-GFP signal (‘‘Full’’).
(G) Kymographs depicting the interaction of 2.5 nM DCX-GFP with dynamic microtubules at 20 mM tubulin (top) and 40 mM tubulin (bottom). The DCX-GFP
signal is similar at the two tubulin concentrations.
(H) Plot of DCX-GFP intensity against the distance from the microtubule end at four different tubulin concentrations (labeled).
(I) Plot of the comet length as a function of tubulin concentration. The comet length does not vary systematically with tubulin concentration.
See also Figure S1.
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constructions [4], although these reconstructions were per-
formedwithGDPmicrotubules only. In spite of this, we recently
demonstrated that DCX binds with highest affinity to microtu-
bule ends [23]. We were curious as to how DCX could recog-
nize microtubule ends in the absence of the contacts found
in EB1. We reasoned that DCX’s end-tracking mechanism
could provide an excellent model system for investigating the
nature of microtubule ends. If DCX recognized a feature of
microtubule ends distinct from nucleotide state, this result
would inform the debate on their nature.
Using a single-molecule fluorescence microscopy assay
[32], we sought to determine howDCX recognizes microtubule
ends.Wediscovered four lines of evidence indicating that DCX
and EB1 recognize distinct features at microtubule ends. DCX
and EB1 differ in the way they ‘‘track’’ microtubule ends and in
the way they bind to microtubules built with GTP analogs.
Importantly, we discovered that DCX recognizes the longi-
tudinal curvature of the microtubule lattice. Reducing the
curvature of microtubule ends using paclitaxel attenuates
end-recognition by DCX, but not EB1. Missense mutationsfound in patients disrupted the recognition of curved lattices
and microtubule ends. Our results support a model in which
DCX recognizes the microtubule end by a novel mechanism
based on lattice curvature.
Results
DCX Comets Behave Differently Than EB1 Comets
Webegan our studywith a comparison of end-tracking byDCX
and EB1 using the single-molecule assay for microtubule-
associated proteins [32]. Figure 1A shows a schematic of our
experiment, in which single microtubule seeds are adhered
to a cover glass surface. A dynamic microtubule extends
from the seed. We added 2.5 nM recombinant DCX-GFP to
our microscope chamber and observed preferential binding
of DCX-GFP to growing microtubule ends. Figure 1B shows
an image of this behavior (see Movie S1 available online),
which is consistent with our previous observations [23]. This
result indicates that the affinity of DCX-GFP is highest for the
microtubule end. In other words, DCX recognizes a feature
of the microtubule end that is distinct from the lattice.
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2368Analysis of the size and shape of EB1-GFP comets has
contributed several insights into the mechanism by which
EB1 recognizes the GTP cap. First, the brightness of EB1-
GFPdecays exponentially along the length of the comet, which
is consistent with the first-order temporal decay of EB1’s bind-
ing site within the GTP cap [33]. Second, EB1-GFP comets
elongate with increasing tubulin concentration, which is
consistent with the GTP cap elongating at faster growth rates
[33]. Third, increasing the EB1-GFP concentration causes the
comets to shrink, suggesting that EB1 somehow catalyzes
the destruction of its own binding site [18], perhaps by accel-
erating tubulin’s GTPase activity through interactions with he-
lix H3 of b-tubulin.
In order to determine whether DCX and EB1 recognize the
same feature of microtubule ends, we asked whether DCX-
GFP comets behave similarly. We first measured the size of
DCX-GFPcometsaswe increased theDCX-GFPconcentration
in the reaction chamber at 10 mM tubulin. Figure 1D shows two
kymographs of DCX-GFP tracking microtubule ends at 2.5 nM
and 5 nM DCX-GFP (see Movie S2). The comets were brighter
and longer at 5 nM DCX-GFP. We averaged the DCX-GFP
signal of n>50comets andfit the result toanexponential decay
function (Figure 1E, solid colored lines); the ‘‘comet length’’ is
reportedas thedecayconstant of thefit,l [33]. Figure1Fshows
a plot of comet length against DCX-GFP concentration. DCX
comets elongated from l = 0.41 6 0.02 mm at 2.5 nM DCX-
GFP, close to a diffraction-limited spot, until a point at which
the entire extension grew outward with a bright DCX-GFP
signal, as previously observed [23]. We refer to these fully
decorated, bright extensions as ‘‘lightsabers’’ (Figure 1C). At
no point did we observe a decreasing DCX-GFP signal at
microtubule ends, which indicates that DCX does not catalyze
the destruction of its own binding site. Whereas increasing the
concentration of EB1 causes the comets to shrink, increasing
the concentration of DCX causes the comets to grow.
We next asked whether DCX-GFP comets elongate with
increasing tubulin concentration. We fixed the DCX-GFP con-
centration at 2.5 nM, varied the tubulin concentration, and
measured the decay length of the DCX-GFP comets (Fig-
ure 1G). In agreement with published results, DCX-GFP did
not itself change the microtubule growth rate ([34] see Fig-
ure S1), and themicrotubules grew faster at higher tubulin con-
centrations, as expected. The comets remained close to a
diffraction-limited spot in all cases (e.g., l = 0.41 6 0.02 mm
at 10 mM tubulin and l = 0.42 6 0.02 mm at 40 mm tubulin,
see Figure 1H). The plot in Figure 1I shows that comet length
does not change systematically with increasing tubulin con-
centrations. In contrast, in our hands EB1-GFP comets elon-
gated linearly with increasing tubulin concentrations (see
Figure S1), growing from l = 0.17 6 0.04 mm at 10 mM tubulin
to l = 0.53 6 0.05 mm at 60 mM tubulin, which is consistent
with previous observations [33].
In order for a protein that recognizes microtubule ends to
create a comet, the protein must dissociate rapidly after the
microtubule end has ‘‘matured’’ into the final lattice. EB1, for
example, has a dissociation rate constant of kd z 4 s
21 at
the microtubule end [33]. For DCX, the kd depends on the
DCX concentration due to the cooperative interactions that
occur between DCX molecules. When many DCX molecules
bind to adjacent sites on the microtubule lattice, their dissoci-
ation rate constants decrease significantly [23]. This fact en-
ables us to interpret the transition of the DCX-GFP signal
from comets to lightsabers. At 2.5 nM DCX-GFP, the signal is
composed primarily of noninteracting single molecules ofDCX-GFP, which have a dissociation rate constant of kd z
1.1 s21 [23]. This rapid dissociation of DCX creates the comets
characteristic of end-tracking. As the DCX concentration in-
creases, many DCX-GFP molecules will bind to the microtu-
bule end within a short time window, and presumably the local
concentration of DCX on the lattice becomes high enough for
cooperative interactions between DCXmolecules to occur. As
a result, the DCX-GFP molecules dissociate more slowly and
the comet elongates. At a sufficiently high concentration, the
lattice will retain nearly all of its DCX-GFP molecules because
of their very slow rate of dissociation. Nevertheless, DCX con-
tinues to recognize the microtubule end as its highest affinity
substrate regardless of concentration, and thus the end con-
tinues to acquire a signal. The result is a lightsaber wherein
DCX-GFP decorates the entire growing microtubule.
DCX Does Not Recognize Two out of Three GTP Analogs
The behavior of DCX-GFP comets suggested to us that DCX
might recognize a distinct feature of microtubule ends. To
test for a nucleotidemechanism, we askedwhether DCX binds
preferentially to microtubules built from GTP analogs. We
adhered fluorescently labeled microtubules built with different
GTP analogs to a cover glass surface. We measured the fluo-
rescence intensity of DCX-GFP bound to microtubules built
from GMPCPP, GTPgS, and GDP-BeF3, and we compared
this intensity with that measured on GDP microtubules in the
same reaction chamber or in back-to-back experiments (see
the Experimental Procedures). These experiments are compli-
cated by the fact that DCX is highly cooperative, with a sigmoid
binding curve that is optimized for 13 pf microtubules [23]. In
fits of the DCX binding curves to the Hill equation, the K value
and Hill coefficient are dominated by the pf-number of the un-
derlying microtubules. GMPCPP microtubules have 14 pf [35],
however, and the pf-numbers of GTPgS andGDP-BeF3-micro-
tubules are not well established. For this reason, the DCX-GFP
concentration was set at 2.5 nM, a single-molecule concentra-
tion at which end-recognition is prominent and at which differ-
ences in binding based on pf-number are not detectable [23].
As a positive control, we performed the same analysis for
200 nM EB1-GFP, which binds preferentially to all three GTP
analogs [17, 18]. As negative controls, we tested tau-GFP
and kinesin-1-GFP, two MAPs that do not share the DCX/
EB1 binding site [36–39] and have not been reported to interact
differentially with microtubule ends.
Figure2Ashows the results forGMPCPP, namelyboxplotsof
the fluorescence intensity on GMPCPP microtubules divided
by the intensity on GDPmicrotubules (see Figure S2 for raw in-
tensity data). At 2.5 nM, DCX-GFP did not bind preferentially to
GMPCPPmicrotubules (IGMPCPP/IGDP = 0.976 0.16). At 200 nM,
EB1-GFPpreferredGMPCPPmicrotubules (IGMPCPP/IGDP=1.36
60.12), asexpected [17],while tauandkinesin-1didnot.Histor-
ically, GMPCPP has been the primary GTP analog for microtu-
bule research, in part because GMPCPP-tubulin polymerizes
at the same rate as GTP-tubulin [40]. Recently, the analog
GTPgS was shown to ‘‘mimic’’ the microtubule end for EB1,
despite the fact that GTPgS-tubulin polymerizes very slowly
and is not capable of spontaneous nucleation [18]. As shown
in Figure 2B, we found that DCX-GFP bound preferentially to
GTPgS microtubules (IGTPgS/IGDP = 1.53 6 0.09). EB1-GFP
also preferred GTPgS microtubules (IGTPgS/IGDP = 1.536 0.14),
as expected [18]. The binding of the negative control proteins,
however, was also altered by GTPgS. At 10 nM, tau showed a
clear preference for GTPgS microtubules (IGTPgS/IGDP = 2.466
0.30), as did 10 nM kinesin-1 (IGTPgS/IGDP = 1.416 0.15). Similar
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Figure 2. DCX Does Not Bind Preferentially to Microtubules Built from Two
out of Three GTP Analogs
(A) Box plot of the intensity of fluorescent protein on aGMPCPPmicrotubule
divided by the intensity on aGDPmicrotubule, IGMPCPP/IGDP. Data are shown
for 2.5 nM DCX-GFP (red), 200 nM EB1-GFP (orange), 10 nM tau-GFP
(green), and 10 nM kinesin-1-GFP (blue).
(B) Box plot of the intensity of fluorescent protein on a GTPgS microtubule
divided by the intensity on a GDP microtubule, IGTPgS/IGDP. Data are shown
for 2.5 nM DCX-GFP (red), 200 nM EB1-GFP (orange), 10 nM tau-GFP
(green), and 10 nM kinesin-1-GFP (blue).
(C) Box plot of the intensity of fluorescent protein on a GDP-BeF3 microtu-
bule divided by the intensity on a GDP microtubule, IGDP-BeF3/IGDP. Data are
shown for 2.5 nMDCX-GFP (red), 200 nM EB1-GFP (orange), 10 nM tau-GFP
(green), and 10 nM kinesin-1-GFP (blue).
See also Figure S2.
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DCX-GFPdid not bind preferentially toGDP-BeF3microtubules
(IGDP-BeF3/IGDP = 1.03 6 0.22), although EB1, tau, and kinesin-1
all preferred GDP-BeF3. High-resolution structures of GTPgS
and GDP-BeF3 microtubules, similar to those of GMPCPP
microtubules [19], will be necessary to determine the mecha-
nism of these pleiotropic effects. While GTPgS microtubules
were essential for the reconstruction of the EB1 binding site
[4], our results indicate that GTPgS andGDP-BeF3 canenhance
the binding of MAPs that do not recognize microtubule ends
and that have binding sites on the outer surface of the micro-
tubule. For comparison, EB1 binds preferentially to all three
GTP analogs, DCX binds preferentially only to GTPgS, andkinesin-1 and tau bind preferentially to GTPgS and GDP-BeF3
analogs.
DCX Recognizes the Longitudinal Curvature of the
Microtubule Lattice
Because DCX does not bind preferentially to two out of three
GTP analogs we tested and DCX comets behave differently,
we wondered if end-recognition might rely on structural fea-
tures of microtubule ends. One hypothesis is that DCX might
recognize the curvature of pfs frequently observed in EM. If
this hypothesis is correct, we predict that DCX should recog-
nize the longitudinal curvature of microtubules in other con-
texts. To test this prediction, we adhered microtubules to
a cover glass surface in the presence of flow. Curved microtu-
bules appear frequently in this process. We introduced 2.5 nM
DCX-GFP into the flow chamber, a concentration at which
end-recognition is apparent. Figure 3A shows an example im-
age, and the curvedmicrotubules showed a brighter DCX-GFP
signal (see also Figure 3B and Movie S3). To confirm this
observation, we measured the absolute curvature, jkj, of our
curved microtubules using a custom software application
based on B-splines. Figure 3C shows a plot in which the
DCX-GFP signal increases with the absolute curvature of the
underlying microtubule lattice. The absolute curvature of our
microtubules ranges from jkj = 0 to 2 mm21, corresponding
to a maximum angular deflection of 1 per tubulin dimer (see
the Supplemental Experimental Procedures). This angle is
similar to that of polymerizing microtubule ends in vitro (5)
[6]. DCX-GFP may have higher affinity at curvatures greater
than those accessible in our experiments. We repeated this
experiment with 200 nM EB1-GFP (Figure 3D). No relationship
between curvature and EB1-GFP brightness could be de-
tected (Figure 3E), and the plot of EB1-GFP signal against jkj
was flat (Figure 3F). These results indicate the DCX binds
specifically to longitudinally curved microtubules.
How does DCX recognize a curved microtubule? Recogni-
tion of longitudinal curvature could be caused by cooperative
interactions between DCX molecules, the means by which
DCX recognizes lateral curvature and pf-number [23]. Alterna-
tively, single DCX molecules might have higher affinity for
curved microtubules. In order to distinguish between these
possibilities, we introduced 0.25 nM DCX-GFP into a flow
chamber containing curved microtubules (Figure 4A) and
imaged the chamber continuously at 10 fps; single molecules
were readily distinguished (Movie S4). We observed a higher
frequency of single molecule events on curved regions (Fig-
ure 4B). To confirm that singlemolecules detected longitudinal
curvature, we averaged the DCX-GFP signal over the experi-
ment; the averaged signal is higher on curved regions (Figures
4C and 4D). To visualize this result another way, Figure 4E
shows a kymograph of a curved microtubule; the measured
curvature, jkj, of themicrotubule at each point is plotted above
the kymograph. More events are observed in the curved re-
gion. These results indicate that the single molecule affinity
of DCX-GFP for microtubules increases when the DCX binding
site has been distorted by curvature and that DCX-GFP senses
longitudinal curvature at the single molecule level while it
senses lateral curvature by a cooperative mechanism. In a
simplified view, there are four distortions possible in the DCX
binding site of a curvedmicrotubule: a convex bend, a concave
bend, and the two transverse shear distortions on the top
and bottom of the curved microtubule. One or more of these
distortions must change the shape of the DCX binding site in
a way that increases the DCX affinity for curved microtubules.
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Figure 3. DCX Recognizes the Longitudinal Cur-
vature of Microtubules
(A) Image of rhodamine-labeled microtubules
(magenta) interacting with 2.5 nM DCX-GFP
(green). A subset of the microtubules curve natu-
rally while binding to the surface of the flow
chamber. DCX-GFP is enriched on the curved
segments.
(B) Inverted grayscale image of DCX-GFP taken
from (A), showing the enrichment on curved
microtubule segments.
(C) Plot of DCX-GFP intensity against the abso-
lute curvature, jkj, of the underlying microtubule.
An approximately linear relationship between
DCX-GFP signal and curvature is observed.
(D) Image of rhodamine-labeled microtubules
(magenta) interacting with 200 nM EB1-GFP
(green), including a subset of curved microtu-
bules. EB1-GFP is not enriched on the curved
segments.
(E) Inverted grayscale image of EB1-GFP taken
from (D), showing the lack of enrichment on
curved microtubule segments.
(F) Plot of EB1-GFP intensity against the absolute
curvature, jkj, of the underlying microtubule. No
relationship between EB1-GFP signal and curva-
ture is observed.
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End-Recognition
If end-recognition by DCX relies on the curvature of protofila-
ments, the prediction is that straightening the pfs at microtu-
bule ends should attenuate or abolish DCX end-recognition.
We tested this prediction using paclitaxel, a microtubule-
stabilizing chemotherapy drug, which has been shown to
straighten pfs at microtubule ends [41, 42]. We added pacli-
taxel to our microtubule growth assays. Figures 5A and 5B
show kymographs of DCX-GFP end-tracking with and without
paclitaxel (note that the images were scaled independently).
We observed a loss of the DCX-GFP end-tracking signal in
the presence of paclitaxel (see Figure S3 for raw intensity
data). We measured the ratio of the brightness at the end to
the brightness on the lattice (IEnd/ILattice, abbreviated here as
IE/IL). For proteins that bind preferentially to microtubule
ends, IE/IL is greater than 1. We measured IE/IL for DCX-GFP
in both conditions, and paclitaxel significantly reduced the ra-
tio (IE/IL = 6.656 2.83 arbitrary units [a.u.] versus IE/IL = 2.136
0.89 a.u., p < 0.001, see Figure 5C). In contrast, we did not
observe changes in the IE/IL ratio for EB1-GFP with paclitaxel
(Figures 5D–5F; IE/IL = 3.16 6 1.47 a.u. versus IE/IL = 3.79 6
1.24 a.u., p = 0.33). This result indicates that DCX end-recogni-
tion is sensitive to the curvature of pfs at microtubule ends.
Missense Mutations Found in Patients Disrupt
Curvature Recognition
Our results above show that DCX recognizes the longitudinal
curvature of microtubule ends and lattices. Is curvature recog-
nition functionally significant? If so,wemight expect thatmuta-
tions that impair DCX function, namely those found in patients
with double cortex syndrome, would be unable to recognize
the longitudinal curvature in microtubules. Patient mutations
in DCX cluster into tandem domains [43], the N-DC and C-DC
domains, that have a common ubiquitin-like fold [44]. We pre-
viously tested eight N-DC mutations and seven C-DC muta-
tions for their ability to bind cooperatively to microtubules
and recognize their lateral curvature [23]. We expressed andpurified these 15 mutants and tested them for recognition of
longitudinal curvature at microtubule ends and lattices using
the assays described above. We identified four mutations
in the C-terminal DC domain for which longitudinal curvature
recognition and end-tracking was abolished or severely
reduced: R178L, P191R, T222I, and G223E. Figures 6A–6C
show a homology model of the C-DC domain with the mutated
residues highlighted. The four mutations map to three ‘‘corner
sites’’ of the C-DC domain that are predicted to bind to tubulin
residues at the vertex of four tubulin dimers [24]. Figure 6D
shows an image of curved paclitaxel microtubules and one
mutant, 25 nM R178L-DCX-GFP, interacting with these micro-
tubules equally, regardless of curvature. Figure 6G shows a
plot of GFP intensity against the jkj of the underlying microtu-
bule for the fourmutants, offset against each other for compar-
ison. No correlation was measurable between jkj and intensity
except for G223E, which showed residual curvature recogni-
tion. The same resultwasobtained at all concentrations tested.
Similarly, Figure 6E shows a kymograph of another mutant,
25 nM P191R-DCX-GFP, interacting with a dynamic microtu-
bule. No preferential binding to the end was observed. Fig-
ure 6H shows a box plot of IE/IL for wild-type DCX and the
four mutants. The IE/IL ratio was reduced to w1 for three of
the mutants (e.g., IE/IL = 1.25 6 0.29 for P191R-DCX-GFP).
Onemutant, G223E, showed less pronounced end-recognition
(IE/IL = 7.36 6 3.23 for DCX-GFP versus IE/IL = 4.48 6 2.39 for
G223E-DCX-GFP, p < 0.05). As above, the same results were
obtained over a range of concentrations. Based on these
findings, we designed two alanine substitutions (H205A and
D213A) in the ‘‘fourth corner’’ of the C-DC domain [24], where
no patient mutations have been reported. These two artificial
mutants also displayed impaired curvature recognition and
end-tracking (Figures 6G and 6H), which consolidates the
conclusion that the C-DC domain is critical for recognition of
longitudinal curvature. Despite their loss of curvature recogni-
tion, all of the mutants retained their preference for GTPgS
microtubules (Figures 6F and 6I). Importantly, end-recognition
and lattice-curvature recognition were both lost or reduced
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Figure 4. Single Molecules of DCX Recognize Longitudinal Curvature
(A) Image of curved paclitaxel microtubules.
(B) Image of 0.25 nM DCX-GFP interacting with the microtubules shown in (A). The white arrows point to single DCX-GFP molecules.
(C) Image of the average signal over 50 s of interactions between DCX-GFP and the microtubules shown in (A). A preference for the curved region of the
microtubules is evident.
(D) Color-combined image of the DCX-GFP average (green) and the underlying microtubules (magenta).
(E) Kymograph showing DCX-GFP interacting with a curved microtubule. The red line above the kymograph shows the absolute curvature, jkj,
of the underlying microtubule. More events occur in the curved region of the microtubule.
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linkage further supports the model that the recognition of
microtubule ends occurs by recognition of a curved structure.
Discussion
Despite their common binding site at the vertex of four tubulin
dimers, we now have four lines of evidence indicating that DCX
and EB1 recognize distinct features at microtubule ends. First,
DCX-GFP does not catalyze the destruction of its own binding
site and DCX-GFP comets do not elongate at faster microtu-
bule growth rates. Second, DCX-GFP does not bind preferen-
tially to GMPCPP or GDP-BeF3 microtubules. Third, DCX-GFP
recognizes the longitudinal curvature of themicrotubule lattice.
Fourth, DCX-GFP end-recognition is attenuated by paclitaxel,
which straightens pfs. DCX is a robust sensor of microtubule
curvature, responding to minute changes in the microtubule
lattice. These results lead us to propose that DCX recognizes
microtubule ends by a novel mechanism based on lattice
curvature.
We showed previously that DCX recognizes the lateral
curvature of the microtubule lattice, a convex curve, by a
mechanism that depends on cooperative interactions between
neighboring DCXmolecules [23]. Our results here have uncov-
ered a novel behavior for DCX: its ability to recognize the lon-
gitudinal curvature of the microtubule lattice, a concave curve,
at the singlemolecule level. To the best of our knowledge, DCX
is the first microtubule-associated protein with this ability.
Other microtubule-associated proteins respond differently to
the ‘‘plasticity’’ and variable curvature of tubulin polymers.
The microtubule polymerase Stu2p, for example, binds to a
curved GTP-tubulin dimer [9]. Conversely, the kinetochore
protein Ndc80 binds preferentially to intact microtubules
over vinblastine-induced protofilament spirals [45], indicating
a preference for straight lattices. Microtubule depolymerases
of the kinesin-13 familymay induce curvature in protofilaments
as a way of promoting catastrophe and depolymerization [20].
In each case, curvature recognition is an integral part of cur-
rent models for these proteins.
The loss of curvature recognition by four patientmutations in
DCX suggests a functional role for this unique ability. DCX isactive in regions in which microtubules can be highly curved
[46], namely growth cones and the sites of collateral branch for-
mation [28]. DCX may use curvature recognition in its interac-
tions with microtubules in these regions. Indeed, a recent
report indicated that RNAi of DCX caused aberrantmicrotubule
curvature in growth cones [47], indicating that DCX may func-
tion to keep microtubule curvature within limits. Alternatively,
DCX might recognize the longitudinal curvature of microtubule
ends as a loading mechanism. Rather than binding directly to
the microtubule lattice, where it might compete with other
microtubule-associated proteins that sterically occlude its
binding site, DCX could get a jump start on the lattice by
loading onto the growing end. We previously argued that
DCX recognizes microtubule ends because they are ‘‘polymer-
ization intermediates,’’ whichwouldmake thempart of amech-
anism to nucleate microtubules with exclusively 13 pfs [23]. If
DCX plays a role in microtubule nucleation in the distal end of
a neuronal process, then recognition of longitudinal curvature
will allow it to target polymerization intermediates in the nucle-
ation pathway. The patient mutants we tested may also suffer
from localization defects, premature degradation, and/or aber-
rant posttranslational modifications that could also contribute
to the disease phenotype. Nevertheless, the loss of curvature
recognition by the four C-DC ‘‘corner mutants’’ is notable.
Our results support the notion that microtubule ends have
two distinct features, namely a structural feature related to
curvature and nucleotide state. This result implies that future
models of microtubule growth must account for curvature at
microtubule ends in addition to the recently established rapid
kinetics of polymerization [48]. We remain agnostic about the
atomic details of these curved features, given the variability
in the EMdata, wheremicrotubule ends are alternately tapered
and curved, sheet-like, or blunt. In schematics, microtubule
ends are commonly drawn with a consistent, intrinsic outward
curvature (e.g., [1]). Microtubule ends are presumably less stiff
than closed tubes, however; a tapered end may sample a
wider range of curvatures when distorted by thermal energy.
Microtubule ends in cells are more curved than those found
in solutions of pure tubulin [6], suggesting that proteins modu-
late the curvature of microtubule ends in vivo. We note that if
all 13 pfs curved outward independently, cracks would appear
A B C
FED
Figure 5. Straightening Protofilaments Attenu-
ates DCX End-Tracking
(A) Kymograph showing the end-tracking be-
havior of 2.5 nM DCX-GFP at 10 mM tubulin.
(B) Kymograph showing the behavior of 2.5 nM
DCX-GFP at 10 mM tubulin with 1 mM paclitaxel.
The DCX-GFP signal at microtubule ends is not
readily distinguishable from the lattice.
(C) Box plot of the intensities at microtubule ends
divided by the intensities on the microtubule lat-
tice for DCX-GFP in the presence and absence
of paclitaxel. The IEnd/ILattice ratio is significantly
reduced by the addition of paclitaxel.
(D) Kymograph showing the end-tracking
behavior of 200 nM EB1-GFP at 10 mM tubulin.
(E) Kymograph showing the behavior of 200 nM
EB1-GFP at 10 mM tubulin with 1 mM paclitaxel.
The EB1-GFP signal at microtubule ends is not
affected by the addition of paclitaxel.
(F) Box plot of the intensities at microtubule ends
divided by the intensities on the microtubule lat-
tice for EB1-GFP in the presence and absence
of paclitaxel. The IEnd/ILattice ratio is not changed
by the addition of paclitaxel.
See also Figure S3.
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Therefore, curvature at microtubule endsmust maintain lateral
contacts between protofilaments, as occurs in models of
sheet-like growth where the intrinsic outward curvature of
pfs competes with the tendency of pfs to close into a tube [13].
There is more than one way to recognize a microtubule end.
EB1 can recognize the nucleotide state but not curvature,
while DCX recognizes curvature but does not recognize two
out of three GTP analogs. Other proteins that recognizemicro-
tubule ends, such as XMAP215 and MCAK, might use still
different mechanisms. At microtubule ends, changes in curva-
ture might be linked to GTP hydrolysis events. The two fea-
tures are separable, however, in that proteins can recognize
one but not the other.
Experimental Procedures
Expression and Purification of DCX, EB1, tau, kinesin-1, and Mutant
Constructs
The coding sequence for human Doublecortin (NCBI Reference Sequence
Database accession number NP_835365) was a gift from Dr. Christopher
Walsh. Human EB1 (GenBank accession number BC109281) was obtained
from Thermo Scientific. The coding sequences for DCX and EB1 were
PCR amplified using PfuX7 polymerase [49] and cloned into a pHAT protein
expression vector as described [50]. The pHAT vector contained anN-termi-
nal poly-His tag followed by a PreScission site and a C-terminal EGFP-tag
followed by a Strep-tag II [51] for affinity purification. DCX-GFP was purified
as described [23] (see the Supplemental Experimental Procedures for de-
tails). Missense mutations in DCX corresponding to those found in human
patients were introduced using site-directed mutagenesis by the Kunkel
method [52]. The cDNA for a constitutively active rat kinesin-1-GFP
(rKin430-GFP) was a gift of Dr. Rob Cross to Dr. Jonathon Howard [53].
rKin430-GFP was expressed and purified as described [54]. The cDNA for
human Tau (GenBank accession number BC114948) was obtained from
Thermo Scientific and purified as described in the the Supplemental Exper-
imental Procedures. Protein concentration and purity were determined us-
ing SDS-PAGE and absorbance at 280 nm and 488 nm using a NanoDrop
spectrophotometer (Thermo Scientific). The eluted proteins were >99%
pure in all cases. The proteins were used fresh and/or aliquots were flash
frozen in LN2 in the presence of 10% glycerol and stored in elution buffer.
Total Internal Reflection Fluorescence Microscopy and Preparation
of Microscope Chambers
The single-molecule dynamic microtubule assay for microtubule-associ-
ated proteins was performed as described [32], with specific modificationsdescribed previously [23]. Microscope chambers were constructed using
custom-machined mounts diagrammed in Gell et al. (2010). In brief, micro-
scope cover glass were silanized as described [55]. A 223 22mm glass and
an 183 18mm glass were separated by double-sided tape, such that a nar-
row channel was created for the exchange of solution. The standard imag-
ing buffer is BRB80 + 10 mMpaclitaxel + 0.1 mg/ml BSA + antifade reagents.
Images were acquired usingMetamorph. Simple measurements of microtu-
bule intensities weremade using the Linescan feature in Metamorph, and all
intensity values are reported asmean6 SD. The absolute values of intensity
are a function of laser power, laser alignment, and camera gain. Camera gain
settings and laser powers were chosen to maximize the sensitivity and dy-
namic range of the camera, which prevents direct comparisons in intensity
values between experiments in some cases. All experiments reported were
repeated in a minimum of three independent trials.
Tubulin and Microtubule Preparations
Tubulin was purified from juvenile bovine brain homogenates as described
[56]. Labeling of cycled tubulin with Alexa Fluor 546 or TAMRA (Invitrogen)
was performed as described [57]; fluorescently labeled tubulin was typically
used at a labeling ratio of 1:4 labeled:unlabeled tubulin dimers. Tubulin was
polymerized into microtubules as follows.
Preparation of Paclitaxel-Stabilized GDP Microtubules
A polymerization mixture was prepared with BRB80 + 32 mM tubulin + 1 mM
GTP + 4mMMgCl2 + 5%DMSO. Themixture was incubated on ice for 5min,
followed by incubation at 37C for 30 min. The polymerized microtubules
were diluted into prewarmed BRB80 + 10 mM paclitaxel, centrifuged at
110,000 rpm (199,000 3 g) in a Beckman Airfuge, and resuspended in
BRB80 + 10 mM paclitaxel.
Microtubule Polymerization in the Presence of GMPCPP
A polymerization mixture was prepared with BRB80 + 2 mM tubulin, 1 mM
GMPCPP (Jena Biosciences), and 1 mMMgCl2. The mixture was incubated
on ice for 5 min, followed by incubation at 37C for 2 hr. The polymerized
GMPCPP microtubules were centrifuged at 110,000 rpm (199,000 3 g) in a
Beckman Airfuge and resuspended in BRB80.
Dynamic Microtubule Assay
Surface-immobilized GMPCPP microtubules were used to elongate dy-
namic microtubules in the presence of GTP. To grow dynamic microtubules
from these ‘‘seeds,’’ imaging buffer containing 10 mM tubulin, 1 mM GTP,
and the protein concentration indicated in the text was introduced in the im-
aging chamber, which is heated to 35C by an objective heater. For the DCX
patient mutations, we tested a range of concentrations for each mutant
(typically 2.5 nM to 100 nM) to account for themutants’ reduced cooperative
binding to microtubules [23].
Comparison of GDP Microtubules and GMPCPP Microtubules
Microtubules were prepared as described in (1) and (2) above, with the
modification that either the GDPmicrotubules or the GMPCPPmicrotubules
were prepared with a lower ratio of fluorescently labeled tubulin, creating,




Figure 6. Missense Mutations in the C-DC Domain Disrupt Curvature Recognition
(A) Homology model of the C-DC domain based on an N-DC structure (Protein Data Bank accession number 2BQQ) from Fourniol et al. [24] showing the
patient mutations used in this study.
(B) The homology model in (A) rotated 180.
(C) Mutations in the C-DC domain that do not affect curvature recognition or end-tracking.
(D) Left: image of curved paclitaxel microtubules. Right: image of the signal averaged over 50 s of interaction between R178L-DCX-GFP and the
microtubules shown at left.
(E) Kymograph depicting the interaction of 25 nM P191R-DCX-GFP with a dynamic microtubule. No preferential binding to microtubule ends is observed.
(F) Example image of a DCX mutant (R178L) binding preferentially to GTPgS extensions.
(G) Plot of GFP intensity against the absolute curvature, jkj, of the underlyingmicrotubule for the four C-DCmutants. No relationship betweenGFP signal and
curvature is observed.
(H) Box plot of the ratio of intensities at microtubule ends divided by the intensities on the microtubule lattice for the four C-DC mutants tested at 20 nM, as
well as for wild-type DCX at 2.5 nM. A ratio of 1 indicates an absence of preferential binding to microtubule ends.
(I) Box plot of intensities of DCX and mutations (20 nM) to GTPgS extensions and GMPCPP seeds.
See also Figure S4.
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chamber using anti-TAMRA antibodies as described [32].
Comparison of GDP Microtubules, GMPCPP Seeds, and GTPgS
Extensions
GMPCPP microtubule seeds were adhered to a cover glass surface as
described above. GTPgS-tubulin was used to elongate these seeds as
described [18]. After elongation, paclitaxel-stabilized GDP microtubules
were introduced into the flow chamber, where they settled onto the surface.
The chamber was rinsed thoroughly and DCX-GFP or control proteins were
introduced. In the case of EB1, the magnitude of its preference for GTP an-
alogs is influenced by the presence of a His tag used for purification [18].
For this reason, we cloned, expressed, and purified a DCX-GFP construct
that lacked a His tag in its sequence. The His-free DCX-GFP construct
behaved identically to His-DCX-GFP-StrepII in all experiments presented
here.
Comparison of GDP Microtubules, GMPCPP Seeds, and GDP-BeF3
Extensions
GDP-BeF3 extensions were prepared as GTPgS extensions with the excep-
tion that GTPgSwas substitutedwith 1mMGTP and 2mMBeF3 (Alfa Aesar).Because BeF3 in solution can populate the nucleotide binding pocket of
GDP microtubules, we compared GDP-BeF3 extensions with GDP microtu-
bules in back-to-back experiments.
Dynamic Assay in the Presence of Paclitaxel
Surface-immobilized GMPCPP-stabilized microtubules were used to elon-
gate dynamicmicrotubules in the presence of GTP. To grow dynamicmicro-
tubules from these ‘‘seeds,’’ imaging buffer containing 10 mM tubulin, 1 mM
GTP, and 2.5 nM DCX-GFP or 200 nM EB1-GFP, with or without 1 mM pacli-
taxel, was introduced in the imaging chamber, which was heated to 35C,
and imaged.
Quantification of Curvature Recognition
Paclitaxel-stabilized GDP microtubules were introduced into a flow cham-
ber as described above. Buffer flow was maintained during the time when
microtubules settled onto the antibody-functionalized cover glass using fil-
ter paper. The continuous flow causes some microtubules to bend. DCX-
GFP in imaging buffer was introduced to flow chambers containing curved
microtubules and images were recorded. Quantification of the microtubule
curvature, jkj, and GFP signal on curved and straight microtubules was
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2374analyzed using ‘‘Kappa,’’ a custom software package based on cubic B-
splines, which are splines comprised of piecewise degree-3 Be´zier curves
(K.L. andG.J.B., unpublished data; see the Supplemental Experimental Pro-
cedures for a complete description).
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, four figures, and four movies and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2014.08.039.
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